Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1 USD | +1,13% | -4,76% | -8,26% |
Omzet 2024 * | 12,22 mln. 11,26 mln. | Omzet 2025 * | 5,87 mln. 5,41 mln. | Marktkapitalisatie | 189 mln. 174 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -24 mln. -22,12 mln. | Nettowinst (verlies) 2025 * | -35 mln. -32,25 mln. | EV/omzet 2024 * | 15,5 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 32,2 x |
K/w-verhouding 2024 * |
-7,69
x | K/w-verhouding 2025 * |
-5,81
x | Werknemers | 72 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,56% |
Recentste transcriptie over Lineage Cell Therapeutics, Inc.
1 dag | +1,13% | ||
1 week | -4,76% | ||
1 maand | -4,76% | ||
3 maanden | -9,91% | ||
6 maanden | +0,65% | ||
Lopend jaar | -8,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17-09-18 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14-11-22 |
Chief Operating Officer | - | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01-07-09 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17-09-18 |
Deborah Andrews
BRD | Director/Board Member | 66 | 11-04-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +3,86% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 1 | +1,13% | 516 151 |
30-05-24 | 0,9888 | +6,32% | 1 141 329 |
29-05-24 | 0,93 | -5,10% | 2 914 510 |
28-05-24 | 0,98 | -6,67% | 3 273 843 |
uitgestelde koers Nyse, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,26% | 189 mln. | |
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. | |
-11,83% | 10,74 mld. |